Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
2,439
Views
28
CrossRef citations to date
0
Altmetric
Editorial

Lurbinectedin: an FDA-approved inducer of immunogenic cell death for the treatment of small-cell lung cancer

Oliver Keppa Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, INSERM UMR1138, Centre de Recherche des Cordeliers, Paris, France;b Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, FranceORCID Iconhttps://orcid.org/0000-0002-6081-9558
ORCID Icon,
Laurence Zitvogelc Gustave Roussy Cancer Center, Inserm U1015, Villejuif, France;d Gustave Roussy Cancer Center, Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France;e Faculty of Medicine, Université Paris Saclay, Le Kremlin-Bicêtre, France;f Chinese Academy of Medical Sciences, Suzhou Institute for Systems Medicine, Suzhou, ChinaORCID Iconhttps://orcid.org/0000-0003-1596-0998
ORCID Icon &
Guido Kroemera Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, INSERM UMR1138, Centre de Recherche des Cordeliers, Paris, France;b Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France;f Chinese Academy of Medical Sciences, Suzhou Institute for Systems Medicine, Suzhou, China;g Pôle De Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France;;h Karolinska Institutet, Department of Women’s and Children’s Health, Karolinska University Hospital, Stockholm, SwedenCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9334-4405
ORCID Icon
Article: 1795995 | Received 09 Jul 2020, Accepted 10 Jul 2020, Published online: 21 Jul 2020

Citations (28)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Yan-jiao Zhang, Chao Huang, Xiu-guang Zu, Jin-ming Liu & Yong-jun Li. (2024) Use of Machine Learning for the Identification and Validation of Immunogenic Cell Death Biomarkers and Immunophenotypes in Coronary Artery Disease. Journal of Inflammation Research 17, pages 223-249.
Read now
Peng Liu, Jianzhou Chen, Liwei Zhao, Antoine Hollebecque, Oliver Kepp, Laurence Zitvogel & Guido Kroemer. (2022) PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer. OncoImmunology 11:1.
Read now
Guido Kroemer & Oliver Kepp. (2021) Small cell lung cancer responds to immunogenic chemotherapy followed by PD-1 blockade. OncoImmunology 10:1.
Read now

Articles from other publishers (25)

Shengqiang Huang, Wenbin Liu, Qiuling Zhao, Ting Chen, Ruyi Huang, Liangliang Dong, Zilin Nian & Lin Yang. (2024) Immunogenic Cell Death-related Signature Evaluates the Tumor Microenvironment and Predicts the Prognosis in Diffuse Large B-Cell Lymphoma. Biochemical Genetics.
Crossref
Gaidaa M. Dogheim, Nourhan E. El Feel, Esraa A. Abd El-Maksod, Sandra Sh. Amer, Sanaa A. El-Gizawy, Ahmed S. Abd Elhamid & Ahmed O. Elzoghby. (2024) Nanomedicines as enhancers of tumor immunogenicity to augment cancer immunotherapy. Drug Discovery Today 29:3, pages 103905.
Crossref
Shuibang Wang & Bruno Guedes Baldi. (2023) Editorial: Reviews in pulmonary medicine 2022. Frontiers in Medicine 10.
Crossref
Guobo Chen, Zhijin Yang, Jun Du, Zongyan He, Yule Zhang, Kejie Zheng, Shuqi Cai, Mengya Chen, Yuhao Li, Lulu Zheng, Yuqing Miao & Dawei Zhang. (2023) Topological Regulating Bismuth Nano‐Semiconductor for Immunogenic Cell Death‐Mediated Sonocatalytic Hyperthermia Therapy. Small 19:48.
Crossref
Shuai Zhang, Liwei Zhao, Mengfei Guo, Peng Liu, Sijing Li, Wei Xie, Ai-Ling Tian, Jonathan G Pol, Hui Chen, Hui Pan, Misha Mao, Yumei Li, Laurence Zitvogel, Yang Jin, Oliver Kepp & Guido Kroemer. (2023) Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses. Journal for ImmunoTherapy of Cancer 11:7, pages e006785.
Crossref
Si-yang Liu, De-jing Huang, En-yu Tang, Ri-xin Zhang, Zhi-ming Zhang, Tong Gao & Guang-quan Xu. (2023) Construction of a non-negative matrix factorization model of immunogenic cell death-related genes in lung adenocarcinoma and analysis of survival prognosis. Heliyon 9:4, pages e14820.
Crossref
Zhengjian Wang, Jin Liu, Yuting Wang, Hui Guo, Fan Li, Yinan Cao, Liang Zhao & Hailong Chen. (2023) Identification of Key Biomarkers Associated with Immunogenic Cell Death and Their Regulatory Mechanisms in Severe Acute Pancreatitis Based on WGCNA and Machine Learning. International Journal of Molecular Sciences 24:3, pages 3033.
Crossref
Fiona Blackhall, Nicolas Girard, Alain Livartowski, Laura McDonald, Montserrat Roset, Nuria Lara & Ariadna Juarez García. (2023) Treatment patterns and outcomes among patients with small-cell lung cancer (SCLC) in Europe: a retrospective cohort study. BMJ Open 13:2, pages e052556.
Crossref
Elaine Lai-Han Leung, Xing-Xing Fan, Ju-Min Huang, Chen Huang, Hong Lin & Ya-Bing Cao. (2023) Holistic immunomodulation for small cell lung cancer. Seminars in Cancer Biology 88, pages 96-105.
Crossref
Jiawei Xu, Yiyi Xiong, Zhou Xu, Hongquan Xing, Lingyun Zhou & Xinyi Zhang. (2022) From targeted therapy to a novel way: Immunogenic cell death in lung cancer. Frontiers in Medicine 9.
Crossref
Yuanyuan Hu, Jiayang Cai, Meng Ye, Qianxue Mou, Bowen Zhao, Qian Sun, Xiaotong Lou, Hong Zhang & Yin Zhao. (2022) Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma. Frontiers in Immunology 13.
Crossref
Jiayang Cai, Yuanyuan Hu, Zhang Ye, Liguo Ye, Lun Gao, Yixuan Wang, Qian sun, Shiao Tong, Ji’an Yang & Qianxue Chen. (2022) Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma. Frontiers in Immunology 13.
Crossref
Xingxing Gao, Hechen Huang, Caixu Pan, Zhibin Mei, Shengyong Yin, Lin Zhou & Shusen Zheng. (2022) Disulfiram/Copper Induces Immunogenic Cell Death and Enhances CD47 Blockade in Hepatocellular Carcinoma. Cancers 14:19, pages 4715.
Crossref
Xingchen Duan, Guo‐Qiang Zhang, Shenglu Ji, Yiming Zhang, Jun Li, Hanlin Ou, Zhiyuan Gao, Guangxue Feng & Dan Ding. (2022) Activatable Persistent Luminescence from Porphyrin Derivatives and Supramolecular Probes with Imaging‐Modality Transformable Characteristics for Improved Biological Applications**. Angewandte Chemie International Edition 61:24.
Crossref
Xingchen Duan, Guo‐Qiang Zhang, Shenglu Ji, Yiming Zhang, Jun Li, Hanlin Ou, Zhiyuan Gao, Guangxue Feng & Dan Ding. (2022) Activatable Persistent Luminescence from Porphyrin Derivatives and Supramolecular Probes with Imaging‐Modality Transformable Characteristics for Improved Biological Applications**. Angewandte Chemie 134:24.
Crossref
Federico Costanzo, Marta Martínez Diez, Gema Santamaría Nuñez, Juan Ignacio Díaz‐Hernandéz, Carlos Mario Genes Robles, Javier Díez Pérez, Emmanuel Compe, Romeo Ricci, Tsai‐Kun Li, Frédéric Coin, Juan Fernando Martínez Leal, Eva Maria Garrido‐Martin & Jean Marc Egly. (2022) Promoters of ASCL1‐ and NEUROD1‐dependent genes are specific targets of lurbinectedin in SCLC cells. EMBO Molecular Medicine 14:4.
Crossref
Guido Kroemer, Claudia Galassi, Laurence Zitvogel & Lorenzo Galluzzi. (2022) Immunogenic cell stress and death. Nature Immunology 23:4, pages 487-500.
Crossref
Zilai Wang, Jiyeon Kim, Pin Zhang, Jazmin M. Galvan Achi, Yuwei Jiang & Lijun Rong. (2022) Current therapy and development of therapeutic agents for lung cancer. Cell Insight 1:2, pages 100015.
Crossref
Chao Chen, Heqi Gao, Hanlin Ou, Ryan T. K. Kwok, Youhong Tang, Donghui Zheng & Dan Ding. (2022) Amplification of Activated Near-Infrared Afterglow Luminescence by Introducing Twisted Molecular Geometry for Understanding Neutrophil-Involved Diseases. Journal of the American Chemical Society 144:8, pages 3429-3441.
Crossref
Dario Matulja, Filip Vranješević, Maria Kolympadi Markovic, Sandra Kraljević Pavelić & Dean Marković. (2022) Anticancer Activities of Marine-Derived Phenolic Compounds and Their Derivatives. Molecules 27:4, pages 1449.
Crossref
Giulia Cerrato, Juliette Humeau, Allan Sauvat, Oliver Kepp & Guido Kroemer. 2022. Radiation Oncology and Radiotherapy Part A. Radiation Oncology and Radiotherapy Part A 67 82 .
Yanhua Li, Xiaohan Liu, Xia Zhang, Wei Pan, Na Li & Bo Tang. (2021) Immunogenic cell death inducers for enhanced cancer immunotherapy. Chemical Communications 57:91, pages 12087-12097.
Crossref
Laurence Zitvogel, Claude Perreault, Olivera J. Finn & Guido Kroemer. (2021) Beneficial autoimmunity improves cancer prognosis. Nature Reviews Clinical Oncology 18:9, pages 591-602.
Crossref
Thais Cristina Mendonça Nogueira & Marcus Vinicius Nora de Souza. (2021) New FDA oncology small molecule drugs approvals in 2020: Mechanism of action and clinical applications. Bioorganic & Medicinal Chemistry 46, pages 116340.
Crossref
Jan Škubník, Vladimíra Pavlíčková & Silvie Rimpelová. (2021) Cardiac Glycosides as Immune System Modulators. Biomolecules 11:5, pages 659.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.